Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin and Topiramate with Calorie-Restricted Diet in Individuals with Excess Weight
IRCT20230114057122N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin and topiramate in obesity, sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2022; status: completed.
02
Drugs
empagliflozintopiramate
03
Conditions
obesity
Beyond the preview
Go deeper on IRCT20230114057122N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230114057122N1.